Search Results

Slidesets
Erwan Vo Quang_COLDA2024_Abstract (2).pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2024
Slidesets
The Role of HIV Integrase Inhibitors in PrEP & PEP- Richard Elion
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
Where are we with long-acting treatment?- David Margolis, MD, MPH
Presented at:
International Workshop on HIV Transmission 2018
Abstracts
Patient-reported outcomes after direct-acting antiviral treatment for chronic hepatitis C in West and Central Africa: the ANRS 12311 TAC trial
M. Bousmah Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Willingness-to-Pay for Sofosbuvir-Based Treatment of Hepatitis C in Africa: Pilot Evidence from the TAC trial ANRS 12311 in Senegal, Côte d’Ivoire and Cameroon
M. Nishmwe Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Slidesets
Jean-Michel Molina | Implementation of PrEP - Efficacy and Resistance Considerations
Presented at:
Asia-Pacific HIV Clinical Forum 2020
Slidesets
Erwan Vo Quang_COLDA2024_Abstract.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2024
Slidesets
Hapatitis C Reinfection after Sustained Virological Response in HIV/HCV Co-Infected Patients | Fábio Videira Santos
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Bakary Dibba_COLDA2024_Abstract.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2024